Marinus Pharmaceuticals reported $3.4M in Trade Debtors for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US USD 56.14M 12.75M
ALKERMES ALKS:US USD 267.28M 4.95M
Amgen AMGN:US USD 5.56B 237M
Biogen BIIB:US USD 1.98B 19.3M
Eisai 4523:JP JPY 178.09B 20.85B
Enanta Pharmaceuticals ENTA:US USD 49.04M 829K
Esperion Therapeutics ESPR:US USD 31.49M 3.64M
Gilead Sciences GILD:US USD 4.78B 423M
Intercept Pharmaceuticals ICPT:US USD 26.17M 1.35M
Intra Cellular Therapies ITCI:US USD 61.54M 14.56M
Marinus Pharmaceuticals MRNS:US USD 3.4M 398K
Neurocrine Biosciences NBIX:US USD 301.2M 22.2M
Ptc Therapeutics PTCT:US USD 124.46M 11.49M
Regeneron Pharmaceuticals REGN:US USD 5.33B 219.6M
Sarepta Therapeutics SRPT:US USD 223.45M 6.82M
Supernus Pharmaceuticals SUPN:US USD 164.09M 6.02M
Vertex Pharmaceuticals VRTX:US USD 1.39B 52.3M
YTE INCY:US USD 618.19M 64.78M